Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.51M Sell
56,814
-137,876
-71% -$5.86M ﹤0.01% 1613
2016
Q3
$7.8M Sell
194,690
-3,226
-2% -$137K ﹤0.01% 981
2016
Q2
$9.45M Buy
197,916
+3,898
+2% +$165K ﹤0.01% 928
2016
Q1
$8.14M Buy
194,018
+2,308
+1% +$90.6K ﹤0.01% 970
2015
Q4
$8.44M Buy
191,710
+178
+0.1% +$7.72K ﹤0.01% 960
2015
Q3
$9.14M Buy
191,532
+84,791
+79% +$4.65M 0.01% 942
2015
Q2
$6.22M Buy
106,741
+75,760
+245% +$4.09M ﹤0.01% 1085
2015
Q1
$1.56M Buy
30,981
+1,209
+4% +$59.3K ﹤0.01% 1608
2014
Q4
$1.34M Sell
29,772
-21,563
-42% -$904K ﹤0.01% 1703
2014
Q3
$1.89M Sell
51,335
-45,943
-47% -$1.82M ﹤0.01% 1441
2014
Q2
$4.29M Buy
97,278
+43,655
+81% +$1.98M ﹤0.01% 1159
2014
Q1
$2.33M Sell
53,623
-44
-0.1% -$1.96K ﹤0.01% 1469
2013
Q4
$2.28M Buy
53,667
+4,351
+9% +$165K ﹤0.01% 1434
2013
Q3
$1.68M Buy
49,316
+6,140
+14% +$200K ﹤0.01% 1574
2013
Q2
$1.35M Buy
+43,176
New +$1.4M ﹤0.01% 1529

Other funds holding CNMD

BlackRock Group's CNMD Position: Q4 2016 in Review

BlackRock Group reduced its CONMED (CNMD) stake by 71% in Q4 2016, selling an estimated $5.86M and leaving 56,814 shares worth $2.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1613.

BlackRock Group first reported a position in CNMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $9.45M in Q2 2016. 147 funds tracked by Wall St. Rank hold CNMD as of Q4 2016.

  • BlackRock Group held 56,814 shares of CONMED worth $2.51M as of Q4 2016.
  • BlackRock Group sold 137,876 CONMED shares in Q4 2016, an estimated $5.86M.
  • CONMED made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1613 holding.
  • BlackRock Group first reported a position in CONMED in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's CONMED position peaked at $9.45M in Q2 2016.
  • 147 funds tracked by Wall St. Rank held CONMED as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.